For instance, OPB-31121, which specifically inhibits STAT3-phosphorylation was recently investigated in patients with advanced solid tumors (but not brain tumors) in a phase I trial [69] and showed the potential to stabilize (n = 8) or reduce (n = 2) tumors (n = 18). The gene discussed is STAT3; the disease is brain neoplasm.